| Page 1808 | Kisaco Research
 

Zahir Dossa

Co-Founder & CEO
Function of Beauty

Zahir Dossa

Co-Founder & CEO
Function of Beauty

Zahir Dossa

Co-Founder & CEO
Function of Beauty
 

Mike Seely

CEO
Native Microbials

Mike Seely

CEO
Native Microbials

Mike Seely

CEO
Native Microbials
 

Yifan Tang

CTO
SF Motors

Yifan Tang

CTO
SF Motors

Yifan Tang

CTO
SF Motors
 

Ty Garibay

VP of Engineering
Mythic

Ty is currently the VP of Engineering at Mythic, where he is leading the development of the first neural network accelerator based on analog computation. Previously, he was CTO at Arteris IP and led IC design teams at Intel/Altera, TI and ARM.  In days past, Ty participated in the development of microprocessors and SoCs at ARM, MIPS, Motorola, Cyrix and Alchemy.  Ty has more than 30 US patents granted. 

Ty Garibay

VP of Engineering
Mythic

Ty Garibay

VP of Engineering
Mythic

Ty is currently the VP of Engineering at Mythic, where he is leading the development of the first neural network accelerator based on analog computation. Previously, he was CTO at Arteris IP and led IC design teams at Intel/Altera, TI and ARM.  In days past, Ty participated in the development of microprocessors and SoCs at ARM, MIPS, Motorola, Cyrix and Alchemy.  Ty has more than 30 US patents granted. 

 

Ritesh Tyagi

Head of Automotive Innovation and Strategy
Infineon

Ritesh Tyagi

Head of Automotive Innovation and Strategy
Infineon

Ritesh Tyagi

Head of Automotive Innovation and Strategy
Infineon
 

Dragos Maciuca

Technical Director
Ford

Dragos Maciuca

Technical Director
Ford

Dragos Maciuca

Technical Director
Ford
 

Issi Rozen

Chief Business Officer
Broad Institute

ISSI ROZEN, Chief Business Officer at the Broad Institute of Harvard and MIT, is responsible for partnering with the life sciences industry and venture investors and developing innovative scientific and business collaborations. He is also responsible for initiating and establishing new ventures around novel technologies and for licensing the institute’s intellectual property portfolio. He joined the Broad in 2011 after a career in the biotech industry. Before joining the Broad Institute, Rozen led corporate development at Resolvyx, a venture-backed biotech start-up.

Issi Rozen

Chief Business Officer
Broad Institute

Issi Rozen

Chief Business Officer
Broad Institute

ISSI ROZEN, Chief Business Officer at the Broad Institute of Harvard and MIT, is responsible for partnering with the life sciences industry and venture investors and developing innovative scientific and business collaborations. He is also responsible for initiating and establishing new ventures around novel technologies and for licensing the institute’s intellectual property portfolio. He joined the Broad in 2011 after a career in the biotech industry. Before joining the Broad Institute, Rozen led corporate development at Resolvyx, a venture-backed biotech start-up. Before that, he headed the business analysis group at EMD Serono where he was responsible for evaluations of in-licensing and M&A opportunities as well as commercial analytics and forecasting for pipeline and commercial products. Issi is a co-founder of a number of biotech start-ups and is an accomplished jazz guitarist. He earned his M.B.A. at MIT’s Sloan School of Management.

 

Dr Andrew Kernytsky

Head of Computational Biology
CRISPR Therapeutics

Dr Andrew Kernytsky

Head of Computational Biology
CRISPR Therapeutics

Dr Andrew Kernytsky

Head of Computational Biology
CRISPR Therapeutics